# Microbial and metabolomic profiling of the upper respiratory tract in children with asthma

**Authors:** Lina Xu, Qianjun Wan, Quying Yang, Wenxin Shen, Yinfang Dai, Huiquan Sun, Li Huang, Meijuan Wang, Wujun Jiang, Chuangli Hao

PMC · DOI: 10.3389/fmicb.2026.1672589 · Frontiers in Microbiology · 2026-02-17

## TL;DR

This study explores how the upper respiratory tract microbiome and metabolome differ in children with asthma compared to healthy children, and how these differences relate to lung function.

## Contribution

The study identifies specific microbial genera and metabolites, such as L-carnitine, that correlate with lung function in children with asthma.

## Key findings

- URT microbiota diversity is lower in acute asthma compared to chronic asthma and healthy controls.
- L-carnitine is a potential biomarker for asthma with high accuracy (AUC > 0.9).
- Metabolic pathways like arginine biosynthesis and central carbon metabolism are altered in asthmatic children.

## Abstract

This study aimed to investigate characteristic changes in the upper respiratory tract (URT) microbiome and metabolome in children with asthma and explore their associations with lung function.

Children with asthma aged 6 years and above admitted to the Children’s Hospital of Soochow University from December 2022 to December 2023 comprised the study group. Age-matched healthy children undergoing physical examinations in the Department of Child Health were recruited as controls. Throat swabs were collected for microbiome detection using 16S rDNA sequencing and metabolomics analysis using liquid chromatography-mass spectrometry (LC–MS).

(1) Significant differences in alpha and beta diversity were observed among the control group (H), chronic persistent asthma group (CA), and acute exacerbation group (AA). In both CA and AA groups, FVC% predicted (FVC%/Pred) and FEV1% predicted (FEV1%/Pred) were negatively correlated with URT microbiota abundance. Actinobacillus abundance was positively correlated with FEV1%/Pred, FEV1/FVC, FEF25%/Pred, FEF50%/Pred, and FEF75%/Pred. (2) Metabolite differences between CA and AA groups were analyzed, and the top 5 differential metabolites were evaluated for their accuracy as asthma assessment biomarkers. L-carnitine showed an AUC > 0.9, with a sensitivity of 85.7% and specificity of 85%. Other differential metabolites, including monoisobutyl phthalate, 4-hexyl-2,5-dimethyloxazole, and dibutyl phthalate, correlated with several lung function indices. The most relevant differential metabolic pathways included arginine biosynthesis, alanine-aspartate–glutamate metabolism, central carbon metabolism in cancer, and D-amino acid metabolism.

The URT microbiota in asthmatic children exhibits alterations in composition, structure, and diversity, with lower diversity in acute asthma compared to chronic persistent asthma. At the genus level, some microbiota (Actinobacillus, Fusobacterium) were correlated with FEV1%/Pred, FEV1/FVC, FEF25%/Pred, FEF50%/Pred, FEF75%/Pred. The differential metabolite L-carnitine may be a potential biomarker for asthma assessment.

## Linked entities

- **Chemicals:** L-carnitine (PubChem CID 288), monoisobutyl phthalate (PubChem CID 92272), 4-hexyl-2,5-dimethyloxazole (PubChem CID 573845), dibutyl phthalate (PubChem CID 3026)
- **Diseases:** asthma (MONDO:0004979)

## Full-text entities

- **Genes:** NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}
- **Diseases:** neutrophilic (MESH:C564275), lung function impairments (MESH:D003072), systemic infectious diseases (MESH:D003141), H (MESH:D000848), cardiac, pulmonary, hepatic, renal, thyroid, neurological, autoimmune, or malignant diseases (MESH:D013967), Asthma (MESH:D001249), Tumor (MESH:D009369), respiratory disease (MESH:D012140), Asthmatic (MESH:D013224), steroid resistance (MESH:D009404), chronic persistent asthma (MESH:D006521), airway inflammation (MESH:D007249), Respiratory infection (MESH:D012141), metabolic (MESH:D008659), airway dysfunction (MESH:D000402), AA (MESH:D000208), airflow obstruction (MESH:D029424), function (MESH:D003291)
- **Chemicals:** propionate (MESH:D011422), arginine (MESH:D001120), fatty acid (MESH:D005227), Dibutyl phthalate (MESH:D003993), CTAB (MESH:D000077286), monoisobutyl phthalate (MESH:C575690), caffeine (MESH:D002110), L-carnitine (MESH:D002331), 4-hexyl-2,5-dimethyloxazole (-), Phthalic anhydride (MESH:C043103), SCFAs (MESH:D005232), Phenanthridine (MESH:D010617), Lipid (MESH:D008055), ammonium acetate (MESH:C018824), agarose (MESH:D012685), acetonitrile (MESH:C032159), alanine (MESH:D000409), carbon (MESH:D002244), lactate (MESH:D019344), nitrogen (MESH:D009584), methanol (MESH:D000432), NO (MESH:D009569), Irbesartan (MESH:D000077405), glutamate (MESH:D018698), acetic acid (MESH:D019342), water (MESH:D014867), benzene (MESH:D001554), Glycerol 3-phosphate (MESH:C029620)
- **Species:** Actinobacillus (genus) [taxon 713], Homo sapiens (human, species) [taxon 9606], Legionella sp. H (species) [taxon 66966], Fusobacterium (genus) [taxon 848], Lactobacillaceae (family) [taxon 33958], Fusobacteriota (phylum) [taxon 32066], Streptococcus (genus) [taxon 1301], Bacteroidota (Bacteroides-Cytophaga-Flexibacter group, phylum) [taxon 976], Gemella (genus) [taxon 1378], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Lactobacillus (genus) [taxon 1578], Prevotella (genus) [taxon 838], Mycobacteriales (order) [taxon 85007], Actinomycetota (actinobacteria, phylum) [taxon 201174], Pseudomonadota (proteobacteria, phylum) [taxon 1224], Veillonella (genus) [taxon 29465], Neisseria (genus) [taxon 482]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12954610/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12954610/full.md

## References

30 references — full list in the complete paper: https://tomesphere.com/paper/PMC12954610/full.md

---
Source: https://tomesphere.com/paper/PMC12954610